Extendicare Stock Performance

EXE Stock  CAD 23.89  0.07  0.29%   
On a scale of 0 to 100, Extendicare holds a performance score of 21. The firm shows a Beta (market volatility) of 0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Extendicare displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield
0.0212
Payout Ratio
0.306
Last Split Factor
43:40
Forward Dividend Rate
0.5
Dividend Date
2026-02-16
1
Extendicare Price Target Increased by 11.61 percent to 19.00 - Nasdaq
11/17/2025
2
Extendicare Inc. Receives Consensus Recommendation of Moderate Buy from Brokerages - MarketBeat
11/20/2025
3
Extendicare Inc. Looks Interesting, And Its About To Pay A Dividend - simplywall.st
11/24/2025
4
Extendicare Mentioned in Multiple Sector Coverage Updates - Kalkine Media
12/05/2025
5
Extendicare Announces December 2025 Dividend of C0.042 per Share - marketscreener.com
12/12/2025
6
Extendicare Is Paying Out A Dividend Of CA0.042 - Yahoo Finance
12/18/2025
7
Investing in Extendicare five years ago would have delivered you a 368 percent gain - Yahoo Finance Canada
01/07/2026
8
Do Extendicares Earnings Warrant Your Attention - simplywall.st
01/14/2026
9
Extendicare Inc. Given Consensus Rating of Buy by Brokerages - MarketBeat
02/02/2026
Begin Period Cash Flow75.2 M
Total Cashflows From Investing Activities-9.1 M
  

Extendicare Relative Risk vs. Return Landscape

If you would invest  1,608  in Extendicare on November 7, 2025 and sell it today you would earn a total of  781.00  from holding Extendicare or generate 48.57% return on investment over 90 days. Extendicare is generating 0.6812% of daily returns assuming 2.5467% volatility of returns over the 90 days investment horizon. Simply put, 22% of all stocks have less volatile historical return distribution than Extendicare, and 87% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Extendicare is expected to generate 3.33 times more return on investment than the market. However, the company is 3.33 times more volatile than its market benchmark. It trades about 0.27 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Extendicare Target Price Odds to finish over Current Price

The tendency of Extendicare Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 23.89 90 days 23.89 
about 9.2
Based on a normal probability distribution, the odds of Extendicare to move above the current price in 90 days from now is about 9.2 (This Extendicare probability density function shows the probability of Extendicare Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Extendicare has a beta of 0.36 suggesting as returns on the market go up, Extendicare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Extendicare will be expected to be much smaller as well. Additionally Extendicare has an alpha of 0.6114, implying that it can generate a 0.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Extendicare Price Density   
       Price  

Predictive Modules for Extendicare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Extendicare. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
21.4323.9826.53
Details
Intrinsic
Valuation
LowRealHigh
23.2925.8428.39
Details
Naive
Forecast
LowNextHigh
21.6024.1526.70
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.270.270.28
Details

Extendicare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Extendicare is not an exception. The market had few large corrections towards the Extendicare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Extendicare, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Extendicare within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.61
β
Beta against Dow Jones0.36
σ
Overall volatility
2.16
Ir
Information ratio 0.23

Extendicare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Extendicare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Extendicare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Extendicare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Extendicare Stock often depends not only on the future outlook of the current and potential Extendicare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Extendicare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding95.4 M
Cash And Short Term Investments121.8 M

Extendicare Fundamentals Growth

Extendicare Stock prices reflect investors' perceptions of the future prospects and financial health of Extendicare, and Extendicare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Extendicare Stock performance.

About Extendicare Performance

By examining Extendicare's fundamental ratios, stakeholders can obtain critical insights into Extendicare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Extendicare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 1.17  1.11 
Return On Tangible Assets 0.11  0.12 
Return On Capital Employed 0.30  0.31 
Return On Assets 0.09  0.10 
Return On Equity 0.54  0.57 

Things to note about Extendicare performance evaluation

Checking the ongoing alerts about Extendicare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Extendicare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Extendicare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Extendicare's stock performance include:
  • Analyzing Extendicare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Extendicare's stock is overvalued or undervalued compared to its peers.
  • Examining Extendicare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Extendicare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Extendicare's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Extendicare's stock. These opinions can provide insight into Extendicare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Extendicare's stock performance is not an exact science, and many factors can impact Extendicare's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Extendicare Stock

Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.